INSUBCONTINENT EXCLUSIVE:
Shares of Advanced Enzyme Technologies rallied as much as 15 per cent.Advanced Enzyme Technologies shares rallied as much as 15 per cent to
hit an intraday high of Rs 422 after the company informed stock exchanges that its systemic enzyme and probiotic supplements ImmunoSEB and
on 200 patients suffering from post COVID fatigue symptoms
The test arm (100 patients) received the oral supplements for 14-days and the control arm (100 patients) received placebo."The randomized
clinical trial was conducted on 200 patients that did not have an active SARS CoV-2 infection, as determined by a negative COVID-19 test,
with a complaint of post-COVID fatigue
Patients were required to have a positive COVID-19 test at any time in the past
The trial was conducted across three centres in India - Swasthya Hospital, Bhopal; Samvedna Hospital, Varanasi; and Chirayu Medical College
- Hospital, Bhopal by Investigators for 14-days," Advanced Enzyme said in a press release."Clinical trials factored positive results in
1:53 pm, Advanced Enzyme shares traded 13 per cent higher at Rs 416, outperforming the Sensex which was down 0.2 per cent.
